Unique gene editing drug could treat genetic blindness, but how it compares to existing therapies
The results of the international preliminary trials look promising and have sent ripples of excitement across the world of medicine. The BRILLIANCE trial — conducted by an American company, Editas Medicine, for its drug called EDIT-101 at various locations …